Issue |
E3S Web Conf.
Volume 434, 2023
4th International Conference on Energetics, Civil and Agricultural Engineering (ICECAE 2023)
|
|
---|---|---|
Article Number | 02032 | |
Number of page(s) | 6 | |
Section | Civil Engineering | |
DOI | https://doi.org/10.1051/e3sconf/202343402032 | |
Published online | 12 October 2023 |
Synthesis of 1-nicotinoylo-3-(meta-nitrophenyl)- thiourea derivatives with anti-inflammatory activity
1 Tashkent Institute of Chemical Technology, Tashkent, 100110, Uzbekistan
2 Andijan State Medical Institute, Andijan, 240030, Uzbekistan
3 Tashkent State Technical University, Tashkent, 100095, Uzbekistan
4 Andijan State University, Andijan, 240016, Uzbekistan
* Corresponding author: valeevang2017@list.ru
Thiourea derivatives are used in many industries: medicine, agriculture, engineering, rubber industry, organic synthesis. On their basis, various preparations for the needs of the national economy were obtained. The latest studies of thiourea derivatives, carried out at the present time, are prompted not only by theoretical, but also by practical needs. From this point of view, thiourea derivatives are of undoubted interest in substances with different biological activities. They are widely used in agriculture and have been used as herbicides, fungicides, insecticides, bactericides, dyes, growth stimulants, etc. Of particular interest is the use of these compounds in medicine as antitumor, antiviral, anti-inflammatory, antiarrhythmic, vasodilator and other drugs. Today, most of the derivatives of thiourea, urea, the search for new highly effective low-toxic biologically active compounds based on them is constantly ongoing, as can be judged by the large number of publications in the world scientific and patent literature. This article proposes a simple and convenient method for the preparation of 1-nicotinoyl-3-(m-nitrophenyl)-thioureas based on heterocyclic thioisocyanate with nitroaniline in a dimethylformamide medium, in rather high yields. And also studied the anti-inflammatory activity of the synthesized drug.
© The Authors, published by EDP Sciences, 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.